News
Sanofi completes $2.5bn Synthorx acquisition
Sanofi has completed its $2.5 billion acquisition of Californian biotech, Synthorx, less than two months after the deal was first announced.
“The acquisition of Synthorx...
Pfizer Vaccines launches first Centre of Excellence
The University of Louisville has been named as Pfizer’s first ‘Centre of Excellence’, part of its Vaccine Division’s global programme of collaborations with academic...
Two-drug combo that halts cancer cell growth discovered
A two-drug combination that halts the growth of cancer cells has been discovered by researchers at UT Southwestern Simmons Cancer Centre.
The findings, published in...
